Related Experiment Videos
Open-label uridine for treatment of depressed adolescents with bipolar disorder
Douglas G Kondo1, Young-Hoon Sung, Tracy L Hellem
1The Brain Institute, University of Utah, Salt Lake City, Utah 84108, USA. doug.kondo@hsc.utah.edu
Abstract:
This report is an open-label case series of seven depressed adolescents with bipolar disorder treated with uridine for 6 weeks. Treatment response was measured with the Children's Depression Rating Scale-Revised and the Clinical Global Impressions scale. Uridine was associated with decreased depressive symptoms, and was well tolerated by study participants. Further systematic studies of uridine are warranted.
Related Concept Videos
Mania and Antimanic Drugs: Overview
Antidepressant Drugs: MAOIs and Other Agents
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Bipolar Disorder
Depressive Disorders: MDD and Dysthymia
Electroconvulsive Therapy